The World Health Organization (WHO) has approved another COVID-19 vaccine for emergency use listing (EUL): Corbevax, a recombinant protein–based vaccine developed by scientists at Texas Children's Hospital and Baylor College of Medicine.
In the period between March and December 2020, twice as many years of life were lost in the poorest areas of the country compared with the wealthiest. Ethnic inequalities were a feature across all waves of the pandemic, with rates of death highest among the Bangladeshi and Pakistani communities.